A+ R A-

IWWM-10 Session 15: Associated and Secondary Malignancy Risks in WM Patients

The following abstracts represent the presentations given at IWWM-10 (NYC-2018), Session 15: Associated and Secondary Malignancy Risks in WM Patients

Session Chair: Alessandra Tedeschi (Italy)

Are WM patients at higher risk for treatment unrelated cancers? J. Castillo (USA)

Should additional cancer screening measures be adopted for WM patients? S. Kastritis (USA)

Therapy-related myeloid neoplasms: Insights from UK R2W Trial R. Owen (UK)

How important are treatment related secondary malignancies in WM? A. Tedeschi (Italy)

New York 2018 (IWWM-10)

New York 2018 Conference Chairs

  • Jorge Castillo, MD (Dana-Farber)
  • Richard Furman, MD (Cornell University)
  • M. Lia Palomba, MD (Memorial Sloan Kettering)
  • Steven Treon, MD, PhD (Dana-Farber)
  • Chris Patterson - Secretariat (Dana-Farber)

The New York 2018 Scientific Committee members:

Ranjana Advani, MD (USA)
Jorge Castillo MD (USA)
Meletios Dimopoulos MD (Greece)
Ramón García-Sanz MD, PhD (Spain)
Zachary Hunter, PhD (USA)
Efstathios Kastritis, MD, PhD (Greece)
Marie Jóse Kersten MD, PhD (Netherlands)
Douglas E Joshua AM (Australia)
Véronique Leblond MD (France)
Giampaolo Merlini MD (Italy)
Roger Owen MD, MRCP, FRCPath (UK)
S.T. Pals, MD, PhD (Netherlands)
Marvin Stone, MD (USA)
Marzia Varretoni, MD (Italy)

Registration for this meeting is now closed.

New York 2018 (IWWM-10) was held at the New York Marriott Downtown in New York City.

New York Marriott Downtown

Click here to download our New York City visitor's guide